0.01Open0.01Pre Close0 Volume614 Open Interest35.00Strike Price0.00Turnover3559.26%IV21.14%PremiumAug 23, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0123Delta0.0132Gamma2890.00Leverage Ratio-17.0624Theta0.0000Rho35.44Eff Leverage0.0000Vega
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.